Headline
The latest stories from AHA Today.
President Trump yesterday signed an executive order to help strengthen the nation’s cybersecurity workforce.
The Department of Commerce’s National Institute of Standards and Technology this week released for comment a draft framework to help organizations that deliver or use data processing systems, products or services manage privacy risk.
Reps. Rosa DeLauro, D-Conn., and Jan Schakowsky, D-Ill., this week introduced the Medicare for America Act, legislation that would create a national health insurance program for most Americans.
Employment at the nation's hospitals rose by 0.16 percent in April to a seasonally adjusted 5,229,200 people, the Bureau of Labor Statistics reported today.
The Federal Trade Commission will hold a public workshop June 18 in Washington, D.C., to assess the impact of certificates of public advantage on health care prices, quality, access and innovation.
The Department of Health and Human Services today issued a final rule protecting certain statutory conscience rights in health care.
The AHA yesterday announced support for the Opioid Workforce Act of 2019, bipartisan legislation to reduce the nation’s shortage of opioid treatment providers by increasing the number of resident physician slots in hospitals with programs focused on substance use disorder treatment.
The AHA today voiced support for provisions in the Mothers and Offspring Mortality and Morbidity Awareness Act (H.R. 1897/S. 916) that would improve state maternal mortality data, provide funding to promote safety practices and cultural competency, and extend health coverage and services for low-…
The Centers for Medicare & Medicaid Services today issued a final rule that eliminates 2014 regulatory text allowing states to reassign Medicaid payments to third parties on behalf of certain providers.
The Centers for Medicare & Medicaid Services will increase the number of opportunities to apply for Healthcare Common Procedure Coding System Level II codes from once per year to quarterly for new drugs and semiannually for new medical devices.